N Hutter1, A Schnurr, H Baumeister. 1. Department of Rehabilitation Psychology and Psychotherapy, Institute of Psychology, University of Freiburg, Engelbergerstr. 41, 79085 Freiburg, Germany. hutter@psychologie.uni-freiburg.de
Abstract
AIMS/HYPOTHESIS: We systematically reviewed the impact of comorbid mental disorders on healthcare costs in persons with diabetes. METHOD: We conducted a comprehensive search for studies investigating adult persons (≥ 18 years old) with diabetes mellitus. All studies that allowed comparison of healthcare costs between diabetic patients with mental disorders and those without were included. RESULTS: We identified 4,273 potentially relevant articles from a comprehensive database search. Of these, 31 primary studies (39 publications) fulfilled inclusion criteria, of which 27 examined comorbid depression. Hospitalisation rates and hospitalisation costs, frequency and costs of outpatient visits, emergency department visits, medication costs and total healthcare costs were mainly increased with small to moderate effect sizes in patients with diabetes and comorbid mental disorders compared with diabetic patients without such problems. Frequency (standardised mean difference [SMD] =0.35-1.26) and costs (SMD =0.33-0.85) of mental health specialist visits were increased in the group with mental health comorbidity. Results regarding diabetes-related preventive services were inconsistent but point to a reduced utilisation rate in diabetic patients with comorbid mental disorders. Statistical heterogeneity between studies was high (I (2) range 64-98%). Pooled overall effects are therefore not reported. Studies included differ substantially regarding sample selection, assessment of diabetes and comorbid mental disorders, as well as in assessment of cost variables. CONCLUSIONS/ INTERPRETATION: In light of the increased healthcare costs and inadequate use of preventive services, comorbid mental disorders in patients with diabetes must become a major focus of diabetes healthcare and research.
AIMS/HYPOTHESIS: We systematically reviewed the impact of comorbid mental disorders on healthcare costs in persons with diabetes. METHOD: We conducted a comprehensive search for studies investigating adult persons (≥ 18 years old) with diabetes mellitus. All studies that allowed comparison of healthcare costs between diabeticpatients with mental disorders and those without were included. RESULTS: We identified 4,273 potentially relevant articles from a comprehensive database search. Of these, 31 primary studies (39 publications) fulfilled inclusion criteria, of which 27 examined comorbid depression. Hospitalisation rates and hospitalisation costs, frequency and costs of outpatient visits, emergency department visits, medication costs and total healthcare costs were mainly increased with small to moderate effect sizes in patients with diabetes and comorbid mental disorders compared with diabeticpatients without such problems. Frequency (standardised mean difference [SMD] =0.35-1.26) and costs (SMD =0.33-0.85) of mental health specialist visits were increased in the group with mental health comorbidity. Results regarding diabetes-related preventive services were inconsistent but point to a reduced utilisation rate in diabeticpatients with comorbid mental disorders. Statistical heterogeneity between studies was high (I (2) range 64-98%). Pooled overall effects are therefore not reported. Studies included differ substantially regarding sample selection, assessment of diabetes and comorbid mental disorders, as well as in assessment of cost variables. CONCLUSIONS/ INTERPRETATION: In light of the increased healthcare costs and inadequate use of preventive services, comorbid mental disorders in patients with diabetes must become a major focus of diabetes healthcare and research.
Authors: Gregory E Simon; Wayne J Katon; Elizabeth H B Lin; Evette Ludman; Michael VonKorff; Paul Ciechanowski; Bessie A Young Journal: Gen Hosp Psychiatry Date: 2005 Sep-Oct Impact factor: 3.238
Authors: Iftekhar D Kalsekar; Suresh M Madhavan; Mayur M Amonkar; Virginia Scott; Stratford M Douglas; Eugene Makela Journal: Manag Care Interface Date: 2006-03
Authors: Martin Härter; Harald Baumeister; Katrin Reuter; Frank Jacobi; Michael Höfler; Jürgen Bengel; Hans-Ulrich Wittchen Journal: Psychother Psychosom Date: 2007 Impact factor: 17.659
Authors: Jeffrey S Gonzalez; Steven A Safren; Enrico Cagliero; Deborah J Wexler; Linda Delahanty; Eve Wittenberg; Mark A Blais; James B Meigs; Richard W Grant Journal: Diabetes Care Date: 2007-05-29 Impact factor: 19.112
Authors: Jayati Das-Munshi; Rob Stewart; Khalida Ismail; Paul E Bebbington; Rachel Jenkins; Martin J Prince Journal: Psychosom Med Date: 2007-07-16 Impact factor: 4.312
Authors: Jennifer S McCall-Hosenfeld; Carol S Weisman; Fabian Camacho; Marianne M Hillemeier; Cynthia H Chuang Journal: Womens Health Issues Date: 2012-01-24
Authors: Samuel L Brilleman; Sarah Purdy; Chris Salisbury; Frank Windmeijer; Hugh Gravelle; Sandra Hollinghurst Journal: Br J Gen Pract Date: 2013-04 Impact factor: 5.386
Authors: Esti Iturralde; Felicia W Chi; Richard W Grant; Constance Weisner; Lucas Van Dyke; Alix Pruzansky; Sandy Bui; Philip Madvig; Robert Pearl; Stacy A Sterling Journal: Diabetes Care Date: 2019-06-18 Impact factor: 19.112